New Index for Multiple Chronic Conditions Predicts Functional Outcome in Ischemic Stroke

Xiaqing Jiang1, Lu Wang1, Lewis B Morgenstern1

  • 1From the Departments of Epidemiology (X.J., L.B.M., L.D.L.) and Biostatistics (L.W.), School of Public Health, University of Michigan; Stroke Program (L.B.M., E.S.C., L.D.L.), Department of Family Medicine (C.T.C.), Department of Internal Medicine (C.T.C.), and Ann Arbor Healthcare System, Department of Physical Medicine and Rehabilitation (E.S.C.), University of Michigan Medical School; and VA Geriatric Research Education and Clinical Center (C.T.C.), Ann Arbor, MI.

Neurology
|October 7, 2020
PubMed

Insights

A new index for multiple chronic conditions (MCCs) effectively predicts functional outcome after ischemic stroke. This tool identifies key predictors and synergistic effects for better patient prognostication.

Area of Science:

  • Neurology
  • Biostatistics
  • Public Health

Background:

  • Multiple chronic conditions (MCCs) complicate stroke recovery and influence functional outcomes.
  • Predictive models for post-stroke functional outcome often lack precision in accounting for complex comorbidities.

Purpose of the Study:

  • To develop and internally validate a novel index for MCCs to predict functional outcome (FO) in patients with ischemic stroke.
  • To identify key chronic conditions and their synergistic interactions that impact post-stroke recovery.

Main Methods:

  • A prospective cohort of ischemic stroke patients (2008-2017) was assessed at baseline and 90 days.
  • Functional outcome was measured using activities of daily living (ADL)/instrumental ADL (IADL) items.
  • Machine learning techniques were employed to develop and weight predictors for the MCC index.

Main Results:

  • The novel MCC index incorporated prestroke modified Rankin Scale (mRS) score, age, congestive heart failure, weight loss, diabetes, other neurologic disorders, and synergistic effects.
  • The index alone explained 31% of the variability in FO and demonstrated good calibration (p=0.41).
  • It accurately predicted unfavorable FO (AUC 0.81) and outperformed the modified Charlson Comorbidity Index.

Conclusions:

  • A new MCC index was successfully developed and validated for predicting post-stroke functional outcome.
  • The index identified novel predictors and synergistic interactions, enhancing prognostic accuracy for ischemic stroke patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
118
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
221